Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a)
Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a)
Active, not recruiting · NCT07551505 · Registry updated 2026-08-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a) | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, metabolic disease | Active, not recruiting | Phase 1 | 2026-08-19 | NCT07551505 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bisirna Therapeutics (Suzhou) Co., Ltd. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking University First Hospital | Beijing | China | 41 |